Watson and the Future of Healthcare (Full Presentation)
IBM’s Watson and future strategies for advancing health. David Kerr, Director, Corporate Strategy, IBM, Armonk, N.Y.
Partnering with the FDA
Michelle Ann Wells, RAC works in Regulatory Affairs at WL GORE and has spent her career navigating the maze known as the FDA. Her 20 year career includes working on the regulatory teams of Schein (Steris/Watson), Zila, The Tech Group, Bard (Impra), Medicis, and Regulatory Compliance Consulting Services. Outside of Arizona, Michelle has worked with Proctor & Gamble, Dey (Mylan), Inale (Nektar), and Pfizer.